Skip Navigation


Rheumatology Advance Access originally published online on February 21, 2008
Rheumatology 2008 47(4):432-436; doi:10.1093/rheumatology/kem377
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
47/4/432    most recent
kem377v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Yao, G.
Right arrow Articles by Li, L.-S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yao, G.
Right arrow Articles by Li, L.-S.
Related Collections
Right arrow Systemic Lupus Erythematosus and Autoimmunity
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Evaluation of renal vascular lesions using circulating endothelial cells in patients with lupus nephritis

G. Yao, Z.-H. Liu, C. Zheng, X. Zhang, H. Chen, C. Zeng and L.-S. Li

Research Institute of Nephrology, Jinling Hospital, Nanjing University Clinical School of Medicine, Nanjing, China.

Correspondence to: Z.-H. Liu, Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, PR China. E-mail: zhihong{at}21cn.net


  Abstract

Objective. Currently the detection of renal vascular lesions (VLS) mainly depends on biopsy examination, and lacks surrogate biomarkers for clinical dynamic evaluation. The aim of this study is to find the correlation between numbers of circulating endothelial cells (CECs) and renal VLS in lupus nephritis (LN).

Methods. Thirty LN patients with VLS and 30 LN patients without VLS were recruited. Thirty age- and sex-matched healthy volunteers served as controls. CECs were isolated from peripheral blood with anti-CD-146-coated immunomagnetic Dynabeads and were counted under microscopy. Parameters of renal involvement, including blood urea nitrogen, serum creatinine, 24 h urine protein excretion and quantitative urine sedimentation were also measured.

Results. The number of CECs showed no difference between LN patients without VLS and controls. In patients with VLS, the number of CECs was significantly higher than those without VLS (P < 0.01). A strong positive correlation was found between CECs and serum creatinine (r = 0.503, P < 0.01) and mean blood pressure (r = 0.423, P < 0.05). In all LN patients with VLS, CEC number of the patients with thrombotic microangiopathy (TMA) significantly increased compared with those without TMA (P < 0.01).

Conclusion. Numeration of CECs may serve as a potential and useful marker for vasculopathy in LN. Dynamic observations of CEC number can be used not only to provide evidence for monitoring disease severity and disease activity, but also to determine therapy efficacy in LN patients.

KEY WORDS: Lupus nephritis, Renal vascular lesion, Circulating endothelial cells

Submitted 17 July 2007; revised version accepted 18 December 2007.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.